TITLE

RESEARCH. Newly diagnosed diabetes mellitus as a risk factor for serious liver disease

AUTHOR(S)
Porepa, Liane; Ray, Joel G.; Sanchez-Romeu, Paula; Booth, Gillian L.
PUB. DATE
August 2010
SOURCE
CMAJ: Canadian Medical Association Journal;8/10/2010, Vol. 182 Issue 11, pE526
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The negative impact of diabetes mellitus is well recognized, yet little is known about the effect of this disease on the liver, an organ susceptible to nonalcoholic fatty liver disease related to insulin resistance. We evaluated whether adults with newly diagnosed diabetes were at increased risk of serious liver disease. Methods: We used administrative health databases for the province of Ontario (1994-2006) to perform a population-based matched retrospective cohort study. The exposed group comprised 438 069 adults with newly diagnosed diabetes. The unexposed comparison group -- those without known diabetes -- consisted of 2 059 708 individuals, matched 5:1 to exposed persons, by birth year, sex and local health region. We excluded individuals with preexisting liver or alcohol-related disease. The primary study outcome was the subsequent development of serious liver disease, namely, liver cirrhosis, liver failure and its sequelae, or receipt of a liver transplant. Results: The incidence rate of serious liver disease was 8.19 per 10 000 person-years among those with newly diagnosed diabetes and 4.17 per 10 000 person-years among those without diabetes. The unadjusted hazard ratio was 1.92 (95% confidence interval [CI] 1.83--2.01). After adjustment for age, income, urban residence, health care utilization and pre-existing hypertension, dyslipidemia, obesity and cardiovascular disease, the hazard ratio was 1.77 (95% CI 1.68--1.86). Interpretation: Adults with newly diagnosed diabetes appeared to be at higher risk of advanced liver disease, also known as diabetic hepatopathy. Whether this reflects nonalcoholic fatty liver disease or direct glycemic injury of the liver remains to be determined.
ACCESSION #
53072390

 

Related Articles

  • Nonalcoholic Liver Disease in Insulin Resistant Adolescents and Response to Metformin. Nadeau, Kristen J.; Ehlers, Lindsay B.; Zeitler, Phillips S.; Love-Osborne, Kathy // Diabetes;Jun2007 Supplement 1, Vol. 56, pA394 

    Nonalcoholic fatty liver disease (NAFLD) is common among adults with type 2 diabetes and insulin resistance. Paralleling the obesity epidemic in youth, NAFLD is also recently recognized in pediatric subjects. Our objective was to estimate the prevalence of NAFLD and its correlates in insulin...

  • Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease. Tolman, Keith G.; Fonseca, Vivian; Dalpiaz, Anthony; Tan, Meng H. // Diabetes Care;Mar2007, Vol. 30 Issue 3, p734 

    The article presents information on a study that reviewed the spectrum of liver disease found in patients with type 2 diabetes and the management of patients with concurrent diabetes and liver disease. Elevation of serum alanine aminotransferase, while uncommon in apparently normal subjects, is...

  • Esteatosis Hepática: ¿Preludio de diabetes tipo 2 en población pediátrica? Loureiro, Carolina; Martínez-Aguayo, Alejandro; Campino, Carmen; Carvajal, Cristián; Fardella, Carlos; García, Hernán // Nutricion Hospitalaria;feb2014, Vol. 29 Issue 2, p350 

    Non alcoholic fatty liver disease (NAFLD) is associated with obesity, insulin resistance (IR) and increased type 2 diabetes (T2D). Alanine aminotransferase (ALT) is recognized as biochemical marker of NAFLD, currently used as screening for this disease. Objective: To estimate the associations...

  • Which Liver Enzymes Are Better Indicators of Metabolic Syndrome in Adolescents: The Fifth Korea National Health and Nutrition Examination Survey, 2010. Lee, Kayoung; Yang, Jin Hyang // Metabolic Syndrome & Related Disorders;Aug2013, Vol. 11 Issue 4, p229 

    Background: This study aimed to examine the relationships of liver enzyme levels with metabolic syndrome in adolescents. Methods: A total of 808 adolescents (430 males and 378 females, aged 10-19 years) participated in the Fifth Korea National Health and Nutrition Examination Survey (KNHANES...

  • Common Genetic Variants Highlight the Role of Insulin Resistance and Body Fat Distribution in Type 2 Diabetes, Independent of Obesity. Scott, Robert A.; Fall, Tove; Pasko, Dorota; Barker, Adam; Sharp, Stephen J.; Arriola, Larraitz; Balkau, Beverley; Barricarte, Aurelio; Barroso, Inês; Boeing, Heiner; Clavel-Chapelon, Françoise; Crowe, Francesca L.; Dekker, Jacqueline M.; Fagherazzi, Guy; Ferrannini, Ele; Forouhi, Nita G.; Franks, Paul W.; Gavrila, Diana; Giedraitis, Vilmantas; Grioni, Sara // Diabetes;Dec2014, Vol. 63 Issue 12, p4378 

    We aimed to validate genetic variants as instruments for insulin resistance and secretion, to characterize their association with intermediate phenotypes, and to investigate their role in type 2 diabetes (T2D) risk among normal-weight, overweight, and obese individuals. We investigated the...

  • Nonalcoholic steatohepatitis: what we know in the new millennium. Harrison, Stephen A.; Kadakia, Shailesh; Lang, Kevin A.; Schenker, Steven // American Journal of Gastroenterology;Nov2002, Vol. 97 Issue 11, p2714 

    Nonalcoholic steatohepatitis (NASH) is a liver disease characterized by diffuse fatty infiltration and inflammation. The exact prevalence of NASH is unclear, but it is becoming more evident that the disease is much more common than previously thought. Although generally a benign, indolent...

  • Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults. Kim, J.; Jo, I. // European Journal of Clinical Nutrition;Feb2010, Vol. 64 Issue 2, p169 

    Background/Objectives:Obesity has been identified as an important factor of elevated alanine aminotransferase (ALT), a surrogate of non-alcoholic fatty liver disease. We investigated the relationship between obesity and elevated ALT in the general Korean population.Subjects/Methods:The study...

  • Acarbose.  // Reactions Weekly;2/25/2006, Issue 1090, p4 

    Presents a case report on liver disorder in a 57-year-old woman. Development of hepatotoxicity during treatment with acarbose for type 2 diabetes mellitus; Decrease in the dosage of the drug due to gastrointestinal discomfort; Withdrawal of the drug after findings of increased alanine...

  • Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus. DE LUIS, D. A.; ALLER, R.; IZAOLA, O.; SAGRADO, M. GONZALEZ; CONDE, R.; DE LA FUENTE, B. // European Review for Medical & Pharmacological Sciences;Aug2013, Vol. 17 Issue 15, p2059 

    BACKGROUND AND OBJECTIVE: The aim of our study was to study the association of insulin resistance expressed by HOMA and adipokines in obese type 2 diabetic patients with or without hyper-transaminasemia. SUBJECTS AND METHODS: A population of 72 obese patients with type 2 diabetes mellitus was...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics